Myocardial inflammation in myocarditis: mechanisms and therapeutic targets - Scorecard - MDSpire

Myocardial inflammation in myocarditis: mechanisms and therapeutic targets

  • By

  • Cristina Madaudo

  • Daniela Di Lisi

  • Francesca Macaione

  • Vincenzo Nuzzi

  • Andrea Micarelli

  • Giusy Sausa

  • Giovanni Castelli

  • Egle Corrado

  • Alfredo Ruggero Galassi

  • Giuseppina Novo

  • June 23, 2026

  • 0 min

Share

Clinical Scorecard: Inflammatory Processes in Myocarditis: Underlying Mechanisms and Potential Treatment Targets

At a Glance

CategoryDetail
ConditionMyocarditis
Key MechanismsInnate and adaptive immune responses, dysregulated inflammatory responses, cytokine signaling, and immune-mediated myocardial injury.
Target PopulationPatients with myocarditis, including those with viral and autoimmune etiologies.
Care SettingClinical assessment and management of inflammatory heart diseases.

Key Highlights

  • Myocarditis can lead to outcomes ranging from recovery to dilated cardiomyopathy.
  • Viral infections are the most common triggers, with parvovirus B19 being frequently implicated.
  • Dysregulated immune responses play a central role in myocardial damage.
  • Emerging biomarkers may assist in risk stratification and monitoring.
  • Targeted immunomodulatory strategies are under investigation for treatment.

Guideline-Based Recommendations

Diagnosis

  • Utilize conventional biomarkers alongside emerging inflammatory markers for diagnosis.

Management

  • Implement guideline-directed heart failure therapy and explore immunomodulatory strategies.

Monitoring & Follow-up

  • Consider immune-derived indices for disease monitoring and risk stratification.

Risks

  • Persistent inflammation can lead to adverse remodeling and progression to heart failure.

Patient & Prescribing Data

Individuals diagnosed with myocarditis, particularly those with viral or autoimmune origins.

Precision approaches are needed to prevent chronic inflammation and myocardial injury.

Clinical Best Practices

  • Focus on understanding immunopathological mechanisms to refine diagnosis and treatment.
  • Integrate biomarker-guided assessments in clinical practice.
  • Monitor patients for signs of persistent inflammation and adverse outcomes.

Related Resources & Content

Original Source(s)

Related Content